The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis

Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur

DOI: 10.46497/ArchRheumatol.2023.9636

Issue: Volume 38 - Issue 2 - June 2023
2107 1618

Pericardial effusion in children admitted with juvenile idiopathic arthritis: A multicenter retrospective cohort study from the pediatric health information system

Daniel Fiedorek, Xinyu Tang, Sukesh Sukumaran, R. Thomas Collins, Elijah Bolin

DOI: 10.46497/ArchRheumatol.2023.9690

Issue: Volume 38 - Issue 3 - September 2023
1895 1572

Association between levels of serum and urinary B cell-activating factor and systemic lupus erythematosus disease activity

Maryam Rezazadeh, Mohammad Hasan Jokar, Seyedeh Mehrnaz Aghili, Zahra Mirfeizi, Mahmoud Mahmoudi, Negar Morovatdar, Kamila Hashemzadeh

DOI: 10.46497/ArchRheumatol.2023.9549

Issue: Volume 38 - Issue 3 - September 2023
2305 1612

Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies

Sherif Gamal, Hanaa Rady, Nesreen Sobhy, Ibrahem Siam, Ahmed Soliman, Fatema Elgengehy

DOI: 10.46497/ArchRheumatol.2023.9860

Issue: Volume 38 - Issue 3 - September 2023
2890 1441

Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?

Rana İşgüder, Zehra Kızıldağ, Rüya Torun, Tuncay Aydın, Balahan Makay, Erbil Ünsal

DOI: 10.46497/ArchRheumatol.2023.10035

Issue: Volume 38 - Issue 4 - December 2023
1855 1242

The effects of Lactobacillus delbrueckii and Lactobacillus rhamnosus on cytokines and their related molecules: An ex vivo study on patients with systemic lupus erythematosus

Atefeh Alaei, Mahmoud Mahmoudi, Maryam Sahebari, Zohreh Vahidi, Nafiseh Tabasi, Maryam Rastin

DOI: 10.46497/ArchRheumatol.2023.9941

Issue: Volume 38 - Issue 4 - December 2023
2292 1573

Left ventricular systolic function assessed by standard and advanced echocardiographic techniques in patients with systemic lupus erythematosus: A systemic review and meta-analysis

Maka Gegenava, Zviad Kirtava, William KF Kong, Tea Gegenava

DOI: 10.46497/ArchRheumatol.2024.10131

Issue: Volume 39 - Issue 1 - March 2024
2068 1311

Unmet needs in psoriatic arthritis, a narrative review

Clementina Lopez-Medina, Umut Kalyoncu, Laure Gossec

DOI: 10.46497/ArchRheumatol.2024.10710

Issue: Volume 39 - Issue 2 - June 2024
4503 2007

Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus

Lingyan He, Mingming Yan, Rui Wen, Jiali Li

DOI: 10.46497/ArchRheumatol.2024.9977

Issue: Volume 39 - Issue 2 - June 2024
1979 1251

Translation, cross-cultural adaptation, reliability, and convergent and known-group validity of the Turkish full version of the Hip Disability and Osteoarthritis Outcome Score in patients with hip osteoarthritis

Ayşenur Gökşen, Remzi Çaylak, Fatma Kübra Çekok, Turhan Kahraman

DOI: 10.46497/ArchRheumatol.2024.10197

Issue: Volume 39 - Issue 2 - June 2024
1828 1075

Prevalence and characteristics of juvenile fibromyalgia syndrome in pediatric rheumatic diseases: A comparative study

Gülcan Özomay Baykal, Duygu Kurtuluş, Serap Ata, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2024.10562

Issue: Volume 39 - Issue 3 - September 2024
1706 977

Validity and reliability of the Turkish version of Exercise Benefits/ Barriers Scale: Perceived exercise benefits and barriers of patients with different axial spondyloarthritis subtypes

Devrim Can Sarac, Elif Durak Ediboglu, Derya Ozer Kaya, Gozde Duran, Emre Alp Akatay, Sercan Gucenmez, Servet Akar, Deniz Bayraktar

DOI: 10.46497/ArchRheumatol.2024.10720

Issue: Volume 39 - Issue 3 - September 2024
2264 1043

New and future perspectives in Behçet's syndrome

Bercemhan Sulu, Gulen Hatemi

DOI: 10.46497/ArchRheumatol.2024.11049

Issue: Volume 39 - Issue 4 - December 2024
4988 3806

Behçet’s Syndrome Overall Damage Index performance and validation in an adult Egyptian cohort

Doaa Attia, Lobna Maged

DOI: 10.46497/ArchRheumatol.2024.10893

Issue: Volume 39 - Issue 4 - December 2024
1037 711

Pediatric to adult rheumatology transition: Success rates, influencing factors, and evolving diagnoses and treatments

Tuba Demirci Yıldırım, Rana İşgüder, Ezgi Karaçura, Yeşim Erez, Balahan Makay, Fatoş Önen, Şevket Erbil Ünsal, İsmail Sarı

DOI: 10.46497/ArchRheumatol.2024.10749

Issue: Volume 39 - Issue 4 - December 2024
1301 808

Lung involvement is a risk factor for treatment resistance in patients with polymyositis and dermatomyositis

Elif Altunel Kılınç, Bengisu Ece Duman, Süleyman Özbek

DOI: 10.46497/ArchRheumatol.2025.10989

Issue: Volume 40 - Issue 1 - March 2025
1361 512